ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 749

Childhood Takayasu Arteritis: Characteristics and Outcomes of a Mexican Cohort

Grissell Alejandra Valero-Gaona1, Enrique Faugier-Fuentes 2 and Angélica Vargas Guerrero 3, 1Departamento de Reumatología, Instituto Nacional de Cardiología "Ignacio Chávez", Ecatepec, Distrito Federal, Mexico, 2Department of Rheumatology, Hospital Infantil de México Federico Gómez, Mexico City, Mexico, 3Departamento de Reumatología del Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: takayasu arteritis and pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 10, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Takayasu arteritis (TA) is a large vessel vasculitis that affects aorta and its main branches. Despite being the third most common vasculitis in childhood, it still rare and data are scarce in the literature. Diagnosis may be delayed due to its non-specific manifestations. Early diagnosis and treatment are essential due to its high morbidity and mortality in these patients.

Methods: A descriptive single-center study of pediatric patients that met the EULAR/PRINTO/PReS criteria for childhood TA (cTA) between January 2000 and April 2019. Demographic data, time to diagnosis, clinical features, laboratory markers, imaging features, extension according to the Numano classification and treatment were documented. Disease activity was retrospectively assessed at the time of diagnosis by Paediatric Vasculitis Activity Score (PVAS). Damage was assessed by Paediatric Vasculitis Damage Index (PVDI) at last follow-up.

Results: Ten patients were included. Demographic data and main features are shown in table 1. Non-specific symptoms were the predominant ones at presentation (90%) followed by more specific manifestations in most cases. In our population, there is a tendency to present extensive vascular disease (Numano V in 50%). Most frequently involved vessels are shown in table 2. All patients were active at the time of their recruitment in our institution (documented by clinical and laboratory findings or by positron emission tomography). Nevertheless, only 40% of them had acute phase reactants elevation (ESR 30% and CRP 30%), which suggests that these analytes do not always correlate with cTA activity. Medical treatment included: glucocorticoids (100%), methotrexate (80%), azathioprine (20%), biological therapy (20%) and others (mycophenolic acid and cyclophosphamide). Six patients (60%) required interventional treatment, five of them (50%) endovascular intervention with stenting. Arteries that required interventional treatment (Stenting) are shown in table 3. Thoracic and abdominal aorta were the more frequently arteries that required surgical replacement with stenting. Two patients required intra-stent balloon angioplasty; one of them required this procedure 3 times. In the first time with placement of a non-medicated stent in one renal artery and twice more placement of medicated stents in both renal arteries because stent restenosis (intra-stent stenting in one side). One patient was treated with balloon angioplasty in both renal arteries and abdominal aorta without stenting. Only three patients (30%) required a surgical procedure. Mortality was 10%, after non-coronary Valsalva sinus plasty with supra-coronary replacement of ascending aorta).

Conclusion: In our cohort, cTA tends to present with extensive vascular disease, associated in most of the cases with nonspecific symptoms. The percentage of acute phase reactants elevation was less than 50% despite having detected cTA activity in 100% of patients at diagnosis, so thorough exploration is essential. Mortality was related to a surgical complication (part of the treatment) and not to the activity of vasculitis.


Demographic data and main features

Table 1. Demographic data and main features


Arterial vessel involvement

Table 2. Arterial vessel involvement


Arteries that required interventional treatment -Stenting-

Table 3. Arteries that required interventional treatment -Stenting-


Disclosure: G. Valero-Gaona, None; E. Faugier-Fuentes, None; A. Vargas Guerrero, None.

To cite this abstract in AMA style:

Valero-Gaona G, Faugier-Fuentes E, Vargas Guerrero A. Childhood Takayasu Arteritis: Characteristics and Outcomes of a Mexican Cohort [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/childhood-takayasu-arteritis-characteristics-and-outcomes-of-a-mexican-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/childhood-takayasu-arteritis-characteristics-and-outcomes-of-a-mexican-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology